AdaptHealth Q2 revenue $806M (+1.6% YoY); net income $19.4M; narrows guidance

AdaptHealth Corp.

2024-Q2 EPS reported $0.12 revenue$1,598,472,000

Net revenue $806.0M vs $793.3M YoY; net income $19.4M (+39%); adjusted EBITDA $165.3M (-3.3%).
Year-to-date operating cash flow $247.0M (+$20.4M YoY); free cash flow $77.9M (+$23.1M).
Signed definitive agreement to divest certain non-core assets; closing expected Q3 2024.
FY2024 guidance: net revenue $3.255-3.315B, adj. EBITDA $660-700M, free cash flow $160-180M.
CEO Suzanne Foster noted results in line with expectations; optimistic about unified team effort.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.